English
新闻公告
More
化学进展 2009, Vol. 21 Issue (12): 2483-2491   后一篇

• 特约稿 •

结构多样性与构效关系——雷公藤新药研究与开发

李征; 李援朝*   

  1. (中国科学院上海药物研究所 上海 201203)
  • 收稿日期:2009-09-24 出版日期:2009-12-24 发布日期:2009-12-01
  • 通讯作者: 李援朝 E-mail:ycli@mail.shcnc.ac.cn

Structural Diversity and Structure-Activity Relationship —— New Drug Research and Development of Tripterygium wilfordii Hook.f.

Li Zheng; Li Yuanchao*   

  1.  (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China)
  • Received:2009-09-24 Online:2009-12-24 Published:2009-12-01
  • Contact: Li Yuanchao E-mail:ycli@mail.shcnc.ac.cn

雷公藤是我国拥有的一种资源比较丰富的传统中草药。其中的主要活性成分雷公藤内酯醇是一种具有3个环氧基团以及一个α, β-不饱和五元内酯环结构的构型独特的松香烷型二萜化合物,具有明显的抗炎、免疫抑制、抗肿瘤及抗雄性生育等生物活性,自被发现以来,吸引了众多药物化学家及药理学家的广泛关注。通过对雷公藤内酯醇结构多样性改造和修饰,包括对C14-位羟基、C12, C13-位环氧、α, β-不饱和五元内酯环、C7,C8-位环氧、C5,C6-位的修饰,以及三环氧开环的改造,合成出了一系列雷公藤内酯醇衍生物,并进行了相关的药理活性测试。总结雷公藤环氧二萜类结构类似物的药理测试结果,初步得出了一些构效关系的特点。随着针对雷公藤内酯醇各个位点进行结构多样性改造所获得的衍生物以及相应的系统性药理活性测试的不断积累与深化,雷公藤内酯醇的结构与活性关系(SAR)也必定越来越明朗。合成低毒性、高活性、宽治疗视窗的雷公藤内酯醇衍生物是该领域众多药物化学家和药理学家的共同目标,从而使雷公藤在更多的领域中具有更广阔的应用前景。

Tripterygium wilfordii Hook.f. (TWHFα), commonly known as Lei Gong Teng (Thunder God Vine), is a vine used in traditional Chinese herbal medicine. Triptolide, the major component responsible for the clinical properties of TWHF, is characterized as an abeo-abietane-typed diterpenoid with a unique triepoxide structure and α, β-unsaturated-5-membered lactone. Right after its isolation, triptolide is shown to possess a broad spectrum of pharmacological activities including anticancer, anti-fertility besides its remarkable anti-inflammatory and immunosuppressive activities, which led to extensive studies. Through the modification of different functional groups in triptolide, including the C14-hydroxyl group, C12β, C13β-epoxy group, α, β-unsaturated-5-membered-lactone ring, C7β, C8β-epoxy group, C5, C6-position, and three epoxy ring-opening transformation etc., a series of derivatives are synthesized and their related pharmacological activities are tested. Some preliminary structure-activity relationship (SAR) characteristics are summarized from the pharmacological test results. With the accumulation and deepening of chemical and biological study of 1, its SAR will be clearer. Low toxicity, high activity, and wide therapeutic window derivatives of 1 will definitely make 1 a broad application prospect in many fields.

Contents
1 The structure modification of C14-hydroxyl group
2 The structure modification of C12β,C13β-epoxy group
3 The structure modification of α,β-unsaturated-5-membered-lactone ring
4 The structure modification of C7β,C8β-epoxy group
5 The structure modification on C5,C6-position
6 Structure modification on other sites, or based on various functional groups
7 Introduction of the structure diversity of TWHF diterpenoid derivatives and their structure-activity relationship(SAR)

中图分类号: 

()

[ 1 ]  赵承嘏(Zhao C G) , 梅斌夫(Mei B F) . 中国生理学杂志(J . Physiology) , 1936 , 10 : 529 —534
[ 2 ]  Qi YM, Musser J H. US 5663335 , 1997
[ 3 ]  Dai D , Fidler J M, Musser J H. US 6569893 , 2003
[ 4 ]  Musser J H , Fidler J M. WO 2009P023201 , 2009
[ 5 ]  Aoyagi Y, Hitotsuyanagi Y, Hasuda T, et al . Bioorganic Medicinal Chemistry Letters , 2006 , 16 (7) : 1947 —1949
[ 6 ]  Kupchan S M, Schubert R M. Science , 1974 , 185 (4153) : 791 — 793
[ 7 ]  Aoyagi Y, Hitotsuyanagi Y, Hasuda T, et al . Bioorg. Med. Chem. Lett . , 2008 , 18 (7) : 2459 —2463
[ 8 ]  于德泉(Yu D Q) , 张东明(Zhang DM) , 王淮滨(Wang HB) 等. 药学学报(Acta Pharmaceutica Sinica) , 1992 , 27 (11) : 830 —836
[ 9 ]  Musser J H. US 6150539 , 2000
[10 ]  Dai D , Yuan H , Musser J H. US 6548537 , 2003
[11 ]  Fidler J M, Musser J H. WO 2005P000291 , 2005
[12 ]  Jung MJ , Wickramaratne M, Hepperle M. US 6004999 , 1999
[13 ]  Li Y C , Zuo J P , Zhang F , et al . WO 2004P058770 , 2004
[14 ]  Jung MJ , Wickramaratne M, Hepperle M. US 5972998 , 1999
[15 ]  Dai D , Musser J H. WO 2004P075853 , 2004

[1] 武江洁星, 魏辉. 浅谈纳米酶的高效设计策略[J]. 化学进展, 2021, 33(1): 42-51.
[2] 闫新, 李意羡, 贾月梅, 俞初一. 糖苷化的亚氨基糖:分离、合成与生物活性[J]. 化学进展, 2019, 31(11): 1472-1508.
[3] 李意羡, 贾月梅, 俞初一. 氟代亚氨基糖的合成与糖苷酶抑制活性[J]. 化学进展, 2018, 30(5): 586-600.
[4] 朱燕燕, 岳宗洋, 边文, 刘瑞林, 马晓迅, 王晓东. 六铝酸盐结构及其在高温反应中的应用[J]. 化学进展, 2018, 30(12): 1992-2002.
[5] 代天志, 孙德群. 抗TB活性化合物的研究[J]. 化学进展, 2018, 30(11): 1784-1802.
[6] 刘如沁, 索志荣, 何乃珍, 陈爽, 黄明. 偶氮桥联二呋咱:合成及其分子结构-熔点的构效关系[J]. 化学进展, 2017, 29(5): 476-490.
[7] 胡代花, 陈旺, 王永吉. 活性维生素D3类似物的合成及构效关系研究[J]. 化学进展, 2016, 28(6): 839-859.
[8] 宋钊宁, 冯翔, 刘熠斌, 杨朝合, 周兴贵. 丙烯直接气相临氢环氧化催化剂结构调控和催化剂构-效关系研究进展[J]. 化学进展, 2016, 28(12): 1762-1773.
[9] 郭键, 贺耘, 叶新山. 唾液酸转移酶抑制剂的设计与发现[J]. 化学进展, 2016, 28(11): 1712-1720.
[10] 赵丽君, 雷鸣. 甲状腺结合前清蛋白的理论研究[J]. 化学进展, 2014, 26(01): 193-202.
[11] 童敏曼, 赵旭东, 解丽婷, 刘大欢*, 阳庆元, 仲崇立*. 金属-有机骨架材料用于废水处理[J]. 化学进展, 2012, (9): 1646-1655.
[12] 张鹭 侯玉霞 袁会珠 覃兆海. 复合物Ⅲ抑制剂型杀菌剂——结构类型和作用机理*[J]. 化学进展, 2010, 22(09): 1852-1868.
[13] 张锁江 姚晓倩 刘晓敏. 离子液体构效关系及应用*[J]. 化学进展, 2009, 21(11): 2465-2473.
[14] 刘华臣,董爱君,高春梅,蒋宇扬. 白藜芦醇结构修饰及药理活性[J]. 化学进展, 2009, 21(0708): 1500-1506.
[15] 刘幸海,董卫莉,张传玉,王宝雷,马翼,李正名. KARI酶及其抑制剂[J]. 化学进展, 2008, 20(11): 1788-1797.